Aurora Cannabis Yönetim

Yönetim kriter kontrolleri 2/4

Aurora Cannabis CEO'su Miguel Martin, Sep2020 tarihinde atandı, in görev süresi 4.17 yıldır. in toplam yıllık tazminatı CA$ 8.02M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.7% maaş ve 90.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.32% ine doğrudan sahiptir ve bu hisseler $ 770.61K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 4.2 yıldır.

Anahtar bilgiler

Miguel Martin

İcra Kurulu Başkanı

CA$8.0m

Toplam tazminat

CEO maaş yüzdesi	9.7%
CEO görev süresi	4.2yrs
CEO sahipliği	0.3%
Yönetim ortalama görev süresi	3.8yrs
Yönetim Kurulu ortalama görev süresi	4.2yrs

Son yönetim güncellemeleri

Recent updates

Aurora Cannabis: Revving Up To Profitability

Aug 08

Aurora launches new cannabis products for adult and medical-use

Oct 17

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Oct 07

Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity

Sep 16

Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry

Jun 05

Aurora Cannabis: Extreme Downside Case Averted

Feb 02

CEO Tazminat Analizi

Miguel Martin'un ücretlendirmesi Aurora Cannabis'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-CA$30m
Jun 30 2024	n/a	n/a	-CA$30m
Mar 31 2024	CA$8m	CA$774k	-CA$55m
Dec 31 2023	n/a	n/a	-CA$116m
Sep 30 2023	n/a	n/a	-CA$153m
Jun 30 2023	n/a	n/a	-CA$195m
Mar 31 2023	CA$7m	CA$591k	-CA$793m
Dec 31 2022	n/a	n/a	-CA$2b
Sep 30 2022	n/a	n/a	-CA$2b
Jun 30 2022	CA$5m	CA$713k	-CA$2b
Mar 31 2022	n/a	n/a	-CA$1b
Dec 31 2021	n/a	n/a	-CA$381m
Sep 30 2021	n/a	n/a	-CA$607m
Jun 30 2021	CA$4m	CA$694k	-CA$692m

Tazminat ve Piyasa: Miguel 'nin toplam tazminatı ($USD 5.73M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.46M ).

Tazminat ve Kazançlar: Miguel şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Miguel Martin (51 yo)

4.2yrs

Görev süresi

CA$8,015,234

Tazminat

Mr. Miguel Martin is Executive Chairman of Aurora Cannabis Inc. from September 20, 2024 and has been the Chief Executive Officer since September 08, 2020 and has been its Director since September 2020 and...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Miguel Martin	CEO & Executive Chairman	4.2yrs	CA$8.02m	0.32% $ 770.6k
Simona King	Chief Financial Officer	less than a year	CA$381.19k	Veri yok
Alex Miller	Executive Vice President of Operations & Supply Chain	2.7yrs	CA$1.38m	0.0042% $ 9.9k
Nathalie Clark	Executive VP	2.7yrs	CA$1.35m	0.00049% $ 1.2k
Andre Jerome	Executive Vice President of Global Business Development	6.8yrs	CA$1.29m	0.038% $ 89.1k
Ananth Krishnan	Vice President of Capital Markets & Investor Relations	no data	Veri yok	Veri yok
Michelle Lefler	Vice President of Communications & Public Relations	no data	Veri yok	Veri yok
Lori Schick	Executive Vice President of Human Resources	3.5yrs	CA$1.61m	0.024% $ 56.2k
Jonathan Page	Senior Science Advisor	6yrs	Veri yok	Veri yok
Rick Savone	Senior Vice President of Global Government Relations	4.9yrs	Veri yok	Veri yok
David Aird	Executive Vice President of Information Technology	2.3yrs	Veri yok	Veri yok
Thomas Larssen	President of Aurora Larssen Projects Ltd.	6.9yrs	Veri yok	Veri yok

3.8yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: ACB 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Miguel Martin	CEO & Executive Chairman	4.2yrs	CA$8.02m	0.32% $ 770.6k
Ronald Funk	Lead Independent Director	6.3yrs	CA$289.99k	0.010% $ 24.6k
Theresa Firestone	Independent Director	3.3yrs	CA$235.00k	0.0063% $ 15.0k
Rajesh Uttamchandani	Independent Director	less than a year	Veri yok	Veri yok
Michael Singer	Independent Director	8.5yrs	CA$219.99k	0.013% $ 31.8k
Norma Beauchamp	Independent Director	6.3yrs	CA$235.00k	Veri yok
Chitwant Kohli	Independent Director	2.8yrs	CA$238.91k	0.011% $ 26.0k

4.2yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ACB 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.2 yıldır).

Aurora Cannabis Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Aurora Cannabis Inc. Announces Board Changes and Changes to Board Committee Compositions

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. Announces CFO Changes

CEO & Director recently bought US$98k worth of stock

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Aurora Cannabis Inc., Annual General Meeting, Nov 14, 2022

Recent updates

Aurora Cannabis Inc. Expands Innovative Recreational Product Portfolio

New minor risk - Profitability

Forecast to breakeven in 2026

Aurora Cannabis Inc. Announces Notice of Proposed Settlement of Class Action Involving All Persons and Entities Who Purchased Aurora Cannabis Inc. Common Stock Between October 23, 2018 and February 28, 2020, Inclusive

Second quarter 2025 earnings released: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)

Aurora Cannabis Inc. to Report Q2, 2025 Results on Nov 06, 2024

Aurora Cannabis Inc. Announces Board Changes and Changes to Board Committee Compositions

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Aurora Cannabis: Revving Up To Profitability

Aurora Cannabis Inc. to Report Q1, 2025 Results on Aug 07, 2024

New minor risk - Profitability

Full year 2024 earnings released: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)

Forecast breakeven date pushed back to 2027

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products

New minor risk - Share price stability

Aurora Cannabis Inc. Announces CFO Changes

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Shareholder dilution

New minor risk - Profitability

Aurora Cannabis Inc. (TSX:ACB) acquired remaining 90% stake in Indica Industries Pty Ltd for AUD 45 million.

Aurora Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q3, 2024 Results on Feb 08, 2024

Forecast to breakeven in 2026

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for Third Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Shareholder dilution

Aurora Cannabis Inc. has completed a Follow-on Equity Offering in the amount of CAD 38.826875 million.

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024

Aurora Cannabis Inc. to Report Q1, 2024 Results on Aug 10, 2023

Bevo Farms Ltd acquired Medicine Hat, Alberta Aurora Sun Facility from Aurora Cannabis Inc. (TSX:ACB) for CAD 15 million.

Now 21% undervalued after recent price drop

CEO & Director recently bought US$98k worth of stock

New minor risk - Profitability

Third quarter 2023 earnings released: CA$0.24 loss per share (vs CA$4.72 loss in 3Q 2022)

Aurora Cannabis Inc. to Report Fiscal Year 2023 Results on Jun 14, 2023

Aurora Celebrates Summer with New Innovation Launching Across Canada

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Forecast to breakeven in 2026

Aurora Cannabis Inc. Reports Impairment Changes for the Quarter Ended December 31, 2022

Second quarter 2023 earnings released

Aurora Cannabis Inc. to Report Q2, 2023 Results on Feb 09, 2023

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD15 million.

Now 20% undervalued after recent price drop

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Forecast to breakeven in 2025

First quarter 2023 earnings released: CA$0.17 loss per share (vs CA$0.06 loss in 1Q 2022)

Aurora Cannabis Inc. to Report Q1, 2023 Results on Nov 10, 2022

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora launches new cannabis products for adult and medical-use

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Full year 2022 earnings: Revenues in line with analyst expectations

Aurora Cannabis Q4 2022 Earnings Preview

Aurora Cannabis Inc. to Report Q4, 2022 Results on Sep 20, 2022

Aurora Cannabis Inc., Annual General Meeting, Nov 14, 2022

Aurora Cannabis Inc. (TSX:ACB) acquired 50.1% stake in Bevo Agtech Inc. for CAD 57 million.

Aurora Cannabis: Don't Let Your Money Go Up In Smoke

Why Did Aurora Cannabis Stock Crash In May; Can It Recover?

Independent Director recently bought US$66k worth of stock

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $150.00125 million.

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $125.195 million.

Aurora Cannabis Inc. Reports Impairment Chargers for the Three Months Ended March 31, 2022

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Recent Developments Do Not Change Our Stance On Aurora Cannabis

Aurora Cannabis Inc. (TSX:ACB) completed the acquisition of TerraFarma, Inc. for CAD 38 million.

Aurora Cannabis: A Train Wreck Desperate For Help